Intra Cellular Therapies | ITCI - Ebitda



Ebitda Cambiamento Data
Acadia Pharmaceuticals USD -1.62M 21.94M 2026-03
ALKERMES USD 139.22M 58.96M 2026-06
BioCryst Pharmaceuticals USD 51.7M 30.14M 2025-09
Biogen USD 649.7M 76.5M 2026-03
Bristol-Myers Squibb USD 4.24B 1.37B 2026-03
Cytokinetics USD -169.32M 19.48M 2026-03
Gilead Sciences USD 3.51B 489M 2026-03
Halozyme Therapeutics USD 328.81M 109.24M 2026-06
J&J USD 8.27B 1.08B 2026-03
Minerva Neurosciences USD -4.36M 1.71M 2024-09
Nektar Therapeutics USD -38.9M 7.09M 2026-03
Neurocrine Biosciences USD 193.3M 25.1M 2026-03
Novartis USD 5.41B 431M 2026-03
Prothena USD 25.98M 65.51M 2026-03
RedHill Biopharma USD 2.69M 108.46M 2023-06
Supernus Pharmaceuticals USD 31.6M 2.37M 2026-06
United Therapeutics USD 355M 11.1M 2026-06
Vanda Pharmaceuticals USD -8.31M 2.37M 2024-12